{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:05:57Z","timestamp":1792789557921,"version":"4.5.0"},"reference-count":131,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health-Ricerca Corrente to Centro Cardiologico Monzino IRCCS","id":[{"id":"https:\/\/ror.org\/006pq9r08","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/006pq9r08","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Acute coronary syndromes (ACS) remain a major cause of cardiovascular mortality and long-term morbidity worldwide despite substantial advances in revascularization techniques, antithrombotic therapies, and lipid-lowering strategies. Although contemporary management has significantly improved survival, a considerable residual risk of recurrent ischemic events, adverse ventricular remodelling, heart failure, and cardiovascular death persists following ACS. Consequently, accurate risk stratification has become increasingly important to guide individualized secondary prevention and optimize long-term outcomes. Traditional risk assessment after ACS relies largely on clinical characteristics, conventional cardiovascular risk factors, and established risk scores such as GRACE and TIMI. However, growing evidence indicates that several emerging biomarkers and pathophysiological pathways provide additional prognostic information beyond conventional models. These markers reflect distinct biological processes including residual inflammatory activity, myocardial injury and remodelling, renal dysfunction, metabolic impairment, and visceral adiposity. This review summarizes current evidence regarding both established and emerging prognostic markers after ACS across six major pathophysiological domains: lipid abnormalities and traditional cardiovascular risk factors; systemic inflammation and residual inflammatory risk; myocardial injury and adverse ventricular remodelling; cardiorenal dysfunction; visceral adiposity; and anti-inflammatory therapeutic strategies. For each domain, we discuss underlying biological mechanisms, key findings from major clinical trials and registries, and the potential incremental value of biomarkers in contemporary risk stratification. Collectively, these markers support a multidimensional approach to post-ACS risk assessment and may contribute to more personalized therapeutic strategies aimed at reducing residual cardiovascular risk.<\/jats:p>","DOI":"10.3390\/jcm15187312","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:09:35Z","timestamp":1790075375000},"page":"7312","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging Prognostic Risk Factors in Acute Coronary Syndromes: Beyond Traditional Risk Assessment"],"prefix":"10.3390","volume":"15","author":[{"given":"Lorenzo","family":"Cangiano","sequence":"first","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4410-4461","authenticated-orcid":false,"given":"Giancarlo","family":"Marenzi","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-6679","authenticated-orcid":false,"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy"},{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy"},{"name":"Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8628-3106","authenticated-orcid":false,"given":"Nicola","family":"Cosentino","sequence":"additional","affiliation":[{"name":"Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy"},{"name":"Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global Burden of Cardiovascular Diseases and Risks, 1990\u20132022","volume":"82","author":"Mensah","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","article-title":"European Society of Cardiology: The 2023 Atlas of Cardiovascular Disease Statistics","volume":"45","author":"Timmis","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jacc.2022.08.767","article-title":"Biomarker-Based Prediction of Recurrent Ischemic Events in Patients with Acute Coronary Syndromes","volume":"80","author":"Batra","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/hrt.2005.084830","article-title":"Intervention in acute coronary syndromes: Do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)","volume":"93","author":"Fox","year":"2007","journal-title":"Heart"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: A prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2514428","article-title":"Evolocumab in Patients without a Previous Myocardial Infarction or Stroke","volume":"394","author":"Bohula","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114960","DOI":"10.4330\/wjc.v18.i2.114960","article-title":"Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies","volume":"18","author":"Tan","year":"2026","journal-title":"World J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5551\/jat.64368","article-title":"Impact of Low-Density Lipoprotein Cholesterol Levels at Acute Coronary Syndrome Admission on Long-Term Clinical Outcomes","volume":"31","author":"Sato","year":"2024","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A Test in Context: Lipoprotein(a)","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, G., Xia, M., Liang, C., Pu, F., Liu, S., and Jia, D. (2024). Prognostic value of elevated lipoprotein (a) in patients with acute coronary syndromes: A systematic review and meta-analysis. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1362893"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacc.2019.10.057","article-title":"Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome","volume":"75","author":"Bittner","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk insights from the FOURIER trial","volume":"139","author":"Fazio","year":"2019","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: Mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: An update","volume":"43","author":"Ambrose","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s40064-016-2188-3","article-title":"The bizzare phenomenon of smokers\u2019 paradox in the immediate outcome post acute myocardial infarction: An insight into the Malaysian National Cardiovascular Database-Acute Coronary Syndrome (NCVD-ACS) registry year 2006\u20132013","volume":"5","author":"Venkatason","year":"2016","journal-title":"Springerplus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/eurheartj\/ehv738","article-title":"Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: The smoker\u2019s paradox revisited","volume":"37","author":"Symons","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6466.","DOI":"10.1038\/s41598-021-86003-w","article-title":"Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention","volume":"11","author":"Sia","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jcmg.2018.05.022","article-title":"Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights","volume":"12","author":"Haig","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gallo, G., Volpe, M., and Savoia, C. (2022). Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Front. Med., 8.","DOI":"10.3389\/fmed.2021.798958"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.hlc.2023.08.007","article-title":"Effect of Antecedent Hypertension on Mortality After Acute Coronary Syndromes in the Coronary Intervention Era: A Meta-analysis","volume":"32","author":"Qi","year":"2023","journal-title":"Heart Lung Circ."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/HYPERTENSIONAHA.117.10786","article-title":"Hypertension, microvascular pathology, and prognosis after an acute myocardial infarction","volume":"72","author":"Carrick","year":"2018","journal-title":"Hypertension"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.amjcard.2009.02.048","article-title":"Meta-Analysis of Adverse Cardiovascular Outcomes Associated with Antecedent Hypertension After Myocardial Infarction","volume":"104","author":"Chen","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1097\/HJH.0b013e328364cbee","article-title":"Impact of hypertension on infarct size in ST elevation myocardial infarction patients undergoing primary angioplasty","volume":"31","author":"Parodi","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12968-016-0299-1","article-title":"Antecedent hypertension and myocardial injury in patients with reperfused ST-elevation myocardial infarction","volume":"18","author":"Reinstadler","year":"2016","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Stampouloglou, P.K., Anastasiou, A., Bletsa, E., Lygkoni, S., Chouzouri, F., Xenou, M., Katsarou, O., Theofilis, P., Zisimos, K., and Tousoulis, D. (2023). Diabetes Mellitus in Acute Coronary Syndrome. Life, 13.","DOI":"10.3390\/life13112226"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and Mortality Following Acute Coronary Syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12933-022-01655-w","article-title":"Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction","volume":"21","author":"Baviera","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Simek, S., Motovska, Z., Hlinomaz, O., Kala, P., Hromadka, M., Knot, J., Varvarovsky, I., Dusek, J., Rokyta, R., and Tousek, F. (2020). The effect of diabetes on prognosis following myocardial infarction treated with primary angioplasty and potent antiplatelet therapy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082555"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4904217","DOI":"10.1155\/2020\/4904217","article-title":"Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications","volume":"2020","author":"Wang","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and Cholesterol Risk in the FOURIER Trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kaura, A., Hartley, A., Panoulas, V., Glampson, B., Shah, A.S.V., Davies, J., Mulla, A., Woods, K., Omigie, J., and Thursz, M.R. (2022). Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. PLoS Med., 19.","DOI":"10.1371\/journal.pmed.1003911"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, X., Wang, S., Fang, S., and Yu, B. (2021). Prognostic Role of High Sensitivity C-Reactive Protein in Patients with Acute Myocardial Infarction. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.659446"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/CRD.0000000000000604","article-title":"Baseline High-Sensitivity C-Reactive Protein as a Predictor of Adverse Clinical Events in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta-Analysis","volume":"33","author":"Yang","year":"2025","journal-title":"Cardiol. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/08820139.2020.1795876","article-title":"Predictive Value of Blood Interleukin-6 Level in Patients with Acute Coronary Syndrome: A Meta-analysis","volume":"50","author":"Li","year":"2021","journal-title":"Immunol. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106806","DOI":"10.1016\/j.vph.2020.106806","article-title":"Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome","volume":"135","author":"Gager","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/08820139.2018.1480034","article-title":"Interleukin-6 as a Predictor of the Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Epidemiological Studies","volume":"47","author":"Zhang","year":"2018","journal-title":"Immunol. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/JAHA.117.005637","article-title":"Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: Observations from the SOLID-TIMI 52 (stabilization of plaque using darapladib-thrombolysis in myocardial infarction 52) trial","volume":"6","author":"Fanola","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4070\/kcj.2013.43.2.93","article-title":"Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention","volume":"43","author":"Han","year":"2013","journal-title":"Korean Circ. J."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhang, S., Diao, J., Qi, C., Jin, J., Li, L., Gao, X., Gong, L., and Wu, W. (2018). Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A meta-analysis. BMC Cardiovasc. Disord., 18.","DOI":"10.1186\/s12872-018-0812-6"},{"key":"ref_46","first-page":"1177","article-title":"Higher Neutrophil\/Lymphocyte Ratio Is Related to Lower Ejection Fraction and Higher Long-term All-Cause Mortality in ST-Elevation Myocardial Infarction Patients","volume":"30","author":"Arbel","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9382","DOI":"10.4238\/2014.November.11.4","article-title":"Relation between neutrophil-to-lymphocyte ratio and severity of coronary artery stenosis","volume":"13","author":"Zhang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4070\/kcj.2016.46.6.768","article-title":"Neutrophil Lymphocyte Ratio as a Predictor of Left Ventricular Apical Thrombus in Patients with Myocardial Infarction","volume":"46","author":"Ertem","year":"2016","journal-title":"Korean Circ. J."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Li, Q., Ma, X., Shao, Q., Yang, Z., Wang, Y., Gao, F., Zhou, Y., Yang, L., and Wang, Z. (2022). Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.811790"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Liu, A., Sun, N., Gao, F., Wang, X., Zhu, H., and Pan, D. (2024). The prognostic value of dynamic changes in SII for the patients with STEMI undergoing PPCI. BMC Cardiovasc. Disord., 24.","DOI":"10.1186\/s12872-023-03679-w"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2872607","DOI":"10.1155\/2019\/2872607","article-title":"Prognostic role of elevated myeloperoxidase in patients with acute coronary syndrome: A systemic review and meta-analysis","volume":"2019","author":"Kolodziej","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13073-025-01531-8","article-title":"Effect of clonal hematopoiesis on plaque morphology and prognosis in patients with acute myocardial infarction","volume":"17","author":"Li","year":"2025","journal-title":"Genome Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40246-025-00757-2","article-title":"Prognostic significance of clonal hematopoiesis in STEMI: A 10-year follow-up reveals high-risk gene mutations","volume":"19","author":"Fan","year":"2025","journal-title":"Hum. Genom."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in Acute Myocardial Infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0735-1097(01)01388-2","article-title":"The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis","volume":"38","author":"Heidenreich","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/hrt.2010.195511","article-title":"Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): Insights from the Global Registry of Acute Coronary Events","volume":"97","author":"Jolly","year":"2011","journal-title":"Heart"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"132556","DOI":"10.1016\/j.ijcard.2024.132556","article-title":"Association between peak troponin level and prognosis among patients admitted to intensive cardiovascular care unit","volume":"417","author":"Loutati","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/heartjnl-2012-301635","article-title":"The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome","volume":"98","author":"Ang","year":"2012","journal-title":"Heart"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0735-1097(00)00942-6","article-title":"Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI-11B substudy","volume":"36","author":"Morrow","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00392-007-0603-z","article-title":"Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment","volume":"97","author":"Iijima","year":"2008","journal-title":"Clin. Res. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.286.19.2405","article-title":"Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic Peptides","volume":"339","author":"Epstein","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1096\/fj.02-0796fje","article-title":"Increased cardiac BNP expression associated with myocardial ischemia","volume":"17","author":"Goetze","year":"2003","journal-title":"FASEB J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2009.03.056","article-title":"Prognostic Value of Biomarkers During and After Non-ST-Segment Elevation Acute Coronary Syndrome","volume":"54","author":"Eggers","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11845-024-03849-5","article-title":"Predictive value of NT-proBNP for major adverse cardiovascular events within a 6-month period in patients with acute coronary syndrome","volume":"194","author":"Ozbaltan","year":"2025","journal-title":"Ir. J. Med. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5603\/KP.2013.0093","article-title":"NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes","volume":"71","author":"Zdravkovic","year":"2013","journal-title":"Kardiol. Pol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"34","DOI":"10.36740\/WLek202201106","article-title":"The Role of Nt-Probnp and St2 Biomarkers in Patients with Acute Coronary Syndrome","volume":"75","author":"Barnett","year":"2022","journal-title":"Wiad. Lek."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"He, P.-C., Duan, C.-Y., Liu, Y.-H., Wei, X.-B., and Lin, S.-G. (2016). N-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction. BMC Cardiovasc. Disord., 16.","DOI":"10.1186\/s12872-016-0430-0"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-8703(99)70148-1","article-title":"Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol","volume":"138","author":"Guazzi","year":"1999","journal-title":"Am. Heart J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0002-9149(99)00495-6","article-title":"Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure","volume":"84","author":"Guazzi","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/cvr\/cvy166","article-title":"Conflicting vascular and metabolic impact of the IL-33\/sST2 axis","volume":"114","author":"Altara","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2018.05.056","article-title":"The IL-33\/ST2 pathway, inflammation and atherosclerosis: Trigger and target?","volume":"267","author":"Aimo","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"BSR20182441","DOI":"10.1042\/BSR20182441","article-title":"Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: A meta-analysis","volume":"39","author":"Gu","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Liu, N., Hang, T., Gao, X., Yang, W., Kong, W., Lou, Q., and Yang, J. (2020). The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238775"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.62347\/HAQL3794","article-title":"Long-term prognostic importance of high levels of sST2 in patient with AMI: A meta-analysis","volume":"16","author":"Ji","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00380-021-01905-z","article-title":"Ability of soluble ST2 to predict left ventricular remodeling in patients with acute coronary syndrome","volume":"37","author":"Park","year":"2022","journal-title":"Heart Vessel."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-021-01244-3","article-title":"Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wischhusen, J., Melero, I., and Fridman, W.H. (2020). Growth\/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00951"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/eurheartj\/ehv491","article-title":"Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: Results from the PLATO study","volume":"37","author":"James","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ajem.2019.04.035","article-title":"Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis","volume":"37","author":"Wang","year":"2019","journal-title":"Am. J. Emerg. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1373\/clinchem.2016.261271","article-title":"Biomarkers and coronary lesions predict outcomes after revascularization in non-ST-elevation acute coronary syndrome","volume":"63","author":"Lindholm","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1038\/s41598-026-38905-w","article-title":"Growth differentiation factor-15 improves long-term mortality risk prediction beyond the GRACE 2.0 score after acute coronary syndrome","volume":"16","author":"Lenell","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_89","first-page":"473","article-title":"Growth differentiation factor 15 is related with left ventricular recovery in patients with st-elevation myocardial infarction after successful reperfusion by primary percutaneous intervention","volume":"37","author":"Somuncu","year":"2021","journal-title":"Acta Cardiol. Sin."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11897-012-0113-9","article-title":"Growth Differentiation Factor 15 in Heart Failure: An Update","volume":"9","author":"Wollert","year":"2012","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_91","first-page":"32","article-title":"Renal dysfunction as an independent predictor of total mortality after acute coronary syndrome: The Thai ACS Registry","volume":"90","author":"Sooklim","year":"2007","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.2147\/IJGM.S334014","article-title":"Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome","volume":"14","author":"Qi","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00380-018-1291-5","article-title":"Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention","volume":"34","author":"Otsuka","year":"2019","journal-title":"Heart Vessel."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/nep.12984","article-title":"Acute Kidney Injury and mortality prognosis in Acute Coronary Syndrome patients: A meta-analysis","volume":"23","author":"Pickering","year":"2018","journal-title":"Nephrology"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Guo, P., Tao, F., Du, L., Yang, H., Wang, W., Ma, C., Bi, X., Ren, L., Yin, H., and Ma, L. (2025). Acute kidney injury after myocardial infarction: Prognostic implications via dual robust methods. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1555478"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"E840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ortega-Hern\u00e1ndez, J., Springall, R., S\u00e1nchez-Mu\u00f1oz, F., Arana-Martinez, J.C., Gonz\u00e1lez-Pacheco, H., and Bojalil, R. (2017). Acute coronary syndrome and acute kidney injury: Role of inflammation in worsening renal function. BMC Cardiovasc. Disord., 17.","DOI":"10.1186\/s12872-017-0640-0"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcu.23265","article-title":"Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease","volume":"50","author":"Prastaro","year":"2022","journal-title":"J. Clin. Ultrasound"},{"key":"ref_100","first-page":"1","article-title":"Prognostic impact of renal function trajectories in patients with STEMI and kidney dysfunction undergoing primary percutaneous coronary intervention: An analysis of ten years all-comers registry","volume":"66","author":"Rey","year":"2022","journal-title":"Hell. J. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus Creatinine in Determining Risk Based on Kidney Function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365513.2020.1846212","article-title":"Predictive value of circulating cystatin C level in patients with acute coronary syndrome: A meta-analysis","volume":"81","author":"Jin","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5603\/cj.102453","article-title":"Diagnostic and prognostic value of cystatin C in acute coronary syndrome: An up-to-date meta-analysis","volume":"32","author":"Pruc","year":"2025","journal-title":"Cardiol. J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijcard.2022.12.025","article-title":"Microalbuminuria during acute coronary syndrome: Association with 22-year mortality and causes of death. The ABC-8* study on heart disease. (*ABC is an acronym for Adria, Bassano, Conegliano, and Padova Hospitals)","volume":"374","author":"Mahmoud","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-012-0853-0","article-title":"Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: A PROVE IT-TIMI 22 substudy","volume":"36","author":"Nazer","year":"2013","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2229","DOI":"10.1002\/hsr2.2229","article-title":"Early neutrophil gelatinase-associated lipocalin (NGAL) measurement could rule out future acute kidney injury in patients with acute coronary syndrome\u2014Prospective observational study","volume":"7","author":"Magnusson","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Byeon, J., Choi, I.J., Lee, D., Ahn, Y., Kim, M.J., and Jeon, D.S. (2022). Predictive and Prognostic Value of Serum Neutrophil Gelatinase-Associated Lipocalin for Contrast-Induced Acute Kidney Injury and Long-Term Clinical Outcomes after Percutaneous Coronary Intervention. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195971"},{"key":"ref_108","first-page":"E984","article-title":"Obesity and Cardiovascular Disease a Scientific Statement from the American Heart Association","volume":"143","author":"Poirier","year":"2021","journal-title":"Circulation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/heartjnl-2011-300231","article-title":"Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: Observations from the MERLIN-TIMI 36 trial","volume":"97","author":"Kadakia","year":"2011","journal-title":"Heart"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1177\/2047487319898019","article-title":"Abdominal obesity and the risk of recurrent atherosclerotic cardiovascular disease after myocardial infarction","volume":"27","author":"Mohammadi","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Krauz, K., Kempi\u0144ski, M., Ja\u0144czak, P., Momot, K., Zar\u0119bi\u0144ski, M., Poprawa, I., and Wojciechowska, M. (2024). The Role of Epicardial Adipose Tissue in Acute Coronary Syndromes, Post-Infarct Remodeling and Cardiac Regeneration. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073583"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Wang, Q., Chi, J., Wang, C., Yang, Y., Tian, R., and Chen, X. (2022). Epicardial Adipose Tissue in Patients with Coronary Artery Disease: A Meta-Analysis. J. Cardiovasc. Dev. Dis., 9.","DOI":"10.3390\/jcdd9080253"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/clc.23692","article-title":"Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue","volume":"44","author":"Mohamed","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Pruc, M., Peacock, F.W., Rafique, Z., Swieczkowski, D., Kurek, K., Tomaszewska, M., Katipoglu, B., Koselak, M., Cander, B., and Szarpak, L. (2023). The Prognostic Role of Platelet-to-Lymphocyte Ratio in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. J. Clin. Med., 12.","DOI":"10.3390\/jcm12216903"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e14295","DOI":"10.1111\/eci.14295","article-title":"The prognostic value of mean platelet volume in patients with coronary artery disease: An updated systematic review with meta-analyses","volume":"54","author":"Galimzhanov","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e41818","DOI":"10.1097\/MD.0000000000041818","article-title":"Mean platelet volume and cardiovascular outcomes in patients with coronary heart disease: A meta-analysis of prospective studies","volume":"105","author":"Wang","year":"2026","journal-title":"Medicine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-9560-7-11","article-title":"Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction","volume":"7","author":"Steppich","year":"2009","journal-title":"Thromb. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-5273(00)00471-X","article-title":"Tissue factor\/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction","volume":"78","author":"Pineda","year":"2001","journal-title":"Int. J. Cardiol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Camera, M., Brambilla, M., Cosentino, N., Becchetti, A., Della Valle, P., Trabattoni, D., Galli, M., Galotta, A., Myasoedova, V., and Bonomi, A. (2025). Tissue Factor, a Membrane-associated Marker of Platelet Activation, Predicts 5-year Cardiovascular Mortality in Coronary Artery Disease Patients. Thromb. Haemost.","DOI":"10.1055\/a-2771-2148"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Cosentino, N., Campodonico, J., Milazzo, V., De Metrio, M., Brambilla, M., Camera, M., and Marenzi, G. (2021). Vitamin D and Cardiovascular Disease: Current Evidence and Future Perspectives. Nutrients, 13.","DOI":"10.3390\/nu13103603"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1871529X14666140228122836","article-title":"Vitamin D and Vitamin D Receptor Activators in Treatment of Hypertension and Cardiovascular Disease","volume":"14","author":"Franczyk","year":"2014","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1586\/erc.10.142","article-title":"Role of vitamin D in arterial hypertension","volume":"8","author":"Pilz","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"101295","DOI":"10.1016\/j.redox.2019.101295","article-title":"Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: Role of renin-angiotensin system","volume":"26","author":"Cui","year":"2019","journal-title":"Redox Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/s41467-020-18538-x","article-title":"Macrophage secretion of miR-106b-5p causes renin-dependent hypertension","volume":"11","author":"Oh","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.amjcard.2012.10.006","article-title":"Relation of Severe Deficiency of Vitamin D to Cardiovascular Mortality During Acute Coronary Syndromes","volume":"111","author":"Correia","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1097\/MD.0000000000000857","article-title":"Vitamin D Plasma Levels and In-Hospital and 1-Year Outcomes in Acute Coronary Syndromes","volume":"94","author":"Milazzo","year":"2015","journal-title":"Medicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejim.2020.08.016","article-title":"Prognostic impact of Vitamin D deficiency in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"83","author":"Verdoia","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1097\/MS9.0000000000002458","article-title":"Effect of vitamin D supplementation on cardiovascular outcomes: An updated meta-analysis of RCTs","volume":"86","author":"Mirza","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1038\/s41598-020-69762-w","article-title":"Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: A systematic review and meta-analysis","volume":"10","author":"Bahrami","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Sarhan, N., Essam Abou Warda, A., Alsahali, S., and Alanazi, A.S. (2023). Impact of Vitamin D Supplementation on the Clinical Outcomes and Epigenetic Markers in Patients with Acute Coronary Syndrome. Pharmaceuticals, 16.","DOI":"10.3390\/ph16020262"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e013958","DOI":"10.1161\/JAHA.119.013958","article-title":"Machine Learning Framework to Identify Individuals at Risk of Rapid Progression of Coronary Atherosclerosis: From the PARADIGM Registry","volume":"9","author":"Han","year":"2020","journal-title":"J. Am. Heart Assoc."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7312\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:34:01Z","timestamp":1790076841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/18\/7312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":131,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15187312"],"URL":"https:\/\/doi.org\/10.3390\/jcm15187312","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]}}}